Publications by authors named "Francesca Elice"

Claim this Profile
I
Impact of mesenchymal stromal/stem cell infusions on circulating inflammatory biomarkers in COVID-19 patients: analysis of a phase I-IIa trial.
Roberto Tonelli, Francesca Pischiutta, Francesca Elice, Elisa R Zanier, Giulia Grisendi

Cytotherapy· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokineinduced killer cells: a first-in-human case report.
Francesca Elice, Roberta Sommaggio, Elisa Cappuzzello, Marcello Riva, Maria Chiara Tisi

Haematologica· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off-the-Shelf Cord-Blood Mesenchymal Stromal Cells: Production, Quality Control, and Clinical Use.
Tiziana Montemurro, Cristiana Lavazza, Elisa Montelatici, Silvia Budelli, Salvatore La Rosa, Francesca Elice

Cells· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia.
Rachele Ciccocioppo, Davide Gibellini, Giuseppe Astori, Martina Bernardi, Angela Bozza, Francesca Elice

Stem Cell Res Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study.
Paola Tacchetti, Lucia Pantani, Francesca Patriarca, Maria Teresa Petrucci, Elena Zamagni, Francesca Elice

Lancet Haematol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Logistics of an advanced therapy medicinal product during COVID-19 pandemic in Italy: successful delivery of mesenchymal stromal cells in dry ice.
Giuseppe Astori, Martina Bernardi, Angela Bozza, Daniela Catanzaro, Katia Chieregato, Francesca Elice

J Transl Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of lymphocytes inactivation by extracorporeal photopheresis using tetrazolium salt based-assay.
Katia Chieregato, Alberta Alghisi, Carlo Borghero, Francesca Elice, Roberto Raimondi

Transfus Apher Sci· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study.
Paola Tacchetti, Carolina Terragna, Monica Galli, Elena Zamagni, Maria Teresa Petrucci, Francesca Elice

Am J Hematol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Side effects of anti-angiogenic drugs.
Francesca Elice, Francesco Rodeghiero

Thromb Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.
Antonio Palumbo, Michele Cavo, Sara Bringhen, Elena Zamagni, Alessandra Romano, Francesca Elice

J Clin Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombotic events in patients with cancer receiving antiangiogenesis agents.
Maurizio Zangari, Louis M Fink, Francesca Elice, Fenghuang Zhan, Dorothy M Adcock

J Clin Oncol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombosis associated with angiogenesis inhibitors.
Francesca Elice, Francesco Rodeghiero, Anna Falanga, Frederick R Rickles

Best Pract Res Clin Haematol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemostatic complications of angiogenesis inhibitors in cancer patients.
Francesca Elice, Jack Jacoub, Frederick R Rickles, Anna Falanga, Francesco Rodeghiero

Am J Hematol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patients.
Maurizio Zangari, Dixie Esseltine, Federica Cavallo, Rachel Neuwirth, Francesca Elice

Am J Hematol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemostatic dysfunction in paraproteinemias and amyloidosis.
Maurizio Zangari, Francesca Elice, Louis Fink, Guido Tricot

Semin Thromb Hemost· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombosis in multiple myeloma.
Maurizio Zangari, Francesca Elice, Louis Fink, Guido Tricot

Expert Rev Anticancer Ther· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism.
Francesca Elice, Louis Fink, Guido Tricot, Bart Barlogie, Maurizio Zangari

Br J Haematol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged overall survival with second on-demand autologous transplant in multiple myeloma.
Francesca Elice, Roberto Raimondi, Alberto Tosetto, Anna D'Emilio, Eros Di Bona

Am J Hematol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study.
Roberto Cairoli, Alessandro Beghini, Giovanni Grillo, Gianpaolo Nadali, Francesca Elice, Felicetto Ferrara

Blood· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory drugs in multiple myeloma.
Maurizio Zangari, Francesca Elice, Guido Tricot

Expert Opin Investig Drugs· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma.
Maurizio Zangari, Dixie Esseltine, Choon-Kee Lee, Bart Barlogie, Francesca Elice

Br J Haematol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma.
Monica Galli, Francesca Elice, Claudia Crippa, Benedetto Comotti, Francesco Rodeghiero

Haematologica· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication.
Alessandro Beghini, Carla B Ripamonti, Roberto Cairoli, Giovanni Cazzaniga, Patrizia Colapietro, Francesca Elice

Haematologica· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of DCEP mobilizing regimen in in vivo purging of PBSC harvests in multiple myeloma.
Elisabetta Novella, Domenico Madeo, Elena Albiero, Sara Roberti, Giancarlo Castaman, Francesca Elice

Leuk Lymphoma· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide and thrombosis.
Francesco Rodeghiero, Francesca Elice

Pathophysiol Haemost Thromb· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis